Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachiko Okamoto

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2020
Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell LeukemiaKoji Kawamura, Yukie Tanaka, Hideki Nakasone, et al.
Journal of Hematology & Oncology|January 8, 2014
Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injuryHiroaki Asai, Hiroshi Fujiwara, Sohei Kitazawa, et al.
Blood|July 27, 2018
Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccinationYasushi Akahori, Linan Wang, Motohiro Yoneyama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 23, 2023
Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft modelYuta Takeuchi, Yizheng Wang, Katsunori Sasaki, et al.
Cancer Letters|June 26, 2026
T-cell receptor-engineered T-cell therapy using a glypican-3-specific TCR derived from a hepatoblastoma vaccine responder for HLA-A2-positive glypican-3-expressing cancersTsuyoshi Terada, Toshihiro Suzuki, Kazunobu Ohnuki, et al.
Cancers|February 11, 2023
Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T CellsOsamu Sato, Takahiro Tsuchikawa, Takuma Kato, et al.
Scientific Reports|August 10, 2023
Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reactionHiroki Hayashi, Jiao Sun, Yuka Yanagida, et al.
Scientific Reports|December 3, 2022
Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variantHiroki Hayashi, Jiao Sun, Yuka Yanagida, et al.
Blood|September 2, 2017
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDSIsao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, et al.
Journal for Immunotherapy of Cancer|June 29, 2022
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndromeMikiya Ishihara, Shigehisa Kitano, Shinichi Kageyama, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2020
Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell LeukemiaKoji Kawamura, Yukie Tanaka, Hideki Nakasone, et al.
Journal of Hematology & Oncology|January 8, 2014
Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injuryHiroaki Asai, Hiroshi Fujiwara, Sohei Kitazawa, et al.
Blood|July 27, 2018
Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccinationYasushi Akahori, Linan Wang, Motohiro Yoneyama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 23, 2023
Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft modelYuta Takeuchi, Yizheng Wang, Katsunori Sasaki, et al.
Cancer Letters|June 26, 2026
T-cell receptor-engineered T-cell therapy using a glypican-3-specific TCR derived from a hepatoblastoma vaccine responder for HLA-A2-positive glypican-3-expressing cancersTsuyoshi Terada, Toshihiro Suzuki, Kazunobu Ohnuki, et al.
Cancers|February 11, 2023
Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T CellsOsamu Sato, Takahiro Tsuchikawa, Takuma Kato, et al.
Scientific Reports|August 10, 2023
Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reactionHiroki Hayashi, Jiao Sun, Yuka Yanagida, et al.
Scientific Reports|December 3, 2022
Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variantHiroki Hayashi, Jiao Sun, Yuka Yanagida, et al.
Blood|September 2, 2017
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDSIsao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, et al.
Journal for Immunotherapy of Cancer|June 29, 2022
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndromeMikiya Ishihara, Shigehisa Kitano, Shinichi Kageyama, et al.
Pageof 4